These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Menopause, estrogens and genital cancer]. Kuttenin F Soins; 1978 Apr; 23(7):23-6. PubMed ID: 249020 [TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement. Nason FG; Nelson BE Obstet Gynecol Clin North Am; 1994 Jun; 21(2):245-70. PubMed ID: 7936544 [TBL] [Abstract][Full Text] [Related]
4. [Cancer risk under hormone therapy]. Lauritzen C Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334 [TBL] [Abstract][Full Text] [Related]
5. The role of sex steroid receptors in obstetrics and gynecology. Roberts DK; Van Sickle M; Kelly RW Obstet Gynecol Annu; 1983; 12():61-78. PubMed ID: 6866353 [TBL] [Abstract][Full Text] [Related]
6. [Receptivity to the sex steroids, physiopathological aspects]. Bercovici JP Contracept Fertil Sex (Paris); 1984 Jun; 12(6):821-7. PubMed ID: 12313177 [TBL] [Abstract][Full Text] [Related]
7. [The present state of research on the relationship of oral contraceptives to breast cancer]. Pike MC Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203 [TBL] [Abstract][Full Text] [Related]
9. The pill and the breast. Drife JO IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402 [TBL] [Abstract][Full Text] [Related]
10. [From the hormonology of mastopathies to breast cancer prevention]. Mauvais-Jarvis P Nouv Presse Med; 1979 May; 8(22):1817-9. PubMed ID: 224379 [No Abstract] [Full Text] [Related]
11. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Saez S; Martin PM; Chouvet CD Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231 [TBL] [Abstract][Full Text] [Related]
12. Potential benefits of estrogens and progestogens on breast cancer. Schneider HP; Jackisch C Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile. Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G Menopause; 2005; 12(5):589-600. PubMed ID: 16145313 [TBL] [Abstract][Full Text] [Related]
15. Use of progestogens in postmenopausal women. Gambrell RD Int J Fertil; 1989; 34(5):315-21. PubMed ID: 2571591 [TBL] [Abstract][Full Text] [Related]
16. Endometrial cancer. Facts and theories. Nordqvist SR Pathol Annu; 1973; 8():283-300. PubMed ID: 4355361 [No Abstract] [Full Text] [Related]
17. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells. Reiner GC; Katzenellenbogen BS Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090 [TBL] [Abstract][Full Text] [Related]
18. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7). Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006 [TBL] [Abstract][Full Text] [Related]
19. Does HRT modify risk of gynecological cancers? Schneider HP; Birkhauser M Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588 [TBL] [Abstract][Full Text] [Related]
20. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]